SEVERE HEPATIC IMPAIRMENT

Clinical trials for SEVERE HEPATIC IMPAIRMENT explained in plain language.

Never miss a new study

Get alerted when new SEVERE HEPATIC IMPAIRMENT trials appear

Sign up with your email to follow new studies for SEVERE HEPATIC IMPAIRMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1 Completed 1

Early safety check: how a drug acts in damaged livers

Knowledge-focused Not yet recruiting

This early-stage study aims to understand how a single dose of the drug vorasidenib is processed by the body in people with severe liver impairment compared to people with normal liver function. It will involve 20 participants who will be closely monitored for safety and have the…

Matched conditions: SEVERE HEPATIC IMPAIRMENT

Phase: PHASE1 • Sponsor: Institut de Recherches Internationales Servier (I.R.I.S.) • Aim: Knowledge-focused

Last updated Mar 19, 2026 14:55 UTC

SEVERE HEPATIC IMPAIRMENT

Get alerted when new SEVERE HEPATIC IMPAIRMENT trials appear

Early safety check: how a drug acts in damaged livers